Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: Results of a prospective phase 2 Spanish/PETHEMA trial

  1. Mateos, M.-V.
  2. Orio, A.
  3. Rosiño, L.
  4. Arriba, F.D.
  5. Puig, N.
  6. Martín, J.
  7. Martínez-López, J.
  8. Echeveste, M.A.
  9. Sarrá, J.
  10. Ocio, E.
  11. Ramírez, G.
  12. Martínez, R.
  13. Palomera, L.
  14. Payer, A.
  15. Iglesias, R.
  16. De Rubia, J.L.
  17. Alegre, A.
  18. Chinea, A.I.
  19. Bladé, J.
  20. Lahuerta, J.J.
  21. Miguel, J.-F.S.
Journal:
Haematologica

ISSN: 1592-8721 0390-6078

Year of publication: 2015

Volume: 100

Issue: 8

Pages: 1096-1102

Type: Article

DOI: 10.3324/HAEMATOL.2015.124818 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals